Jean Claude Dusingize is currently enrolled in Clinical research training program which is a two-year program consisting of a didactic curriculum and a mentored experience leading to a Master of Science Degree in Clinical Research Methods.
Jean Claude's current research project supported by AITRP aims at determining insulin resistance and its relationship with antiretroviral therapy in treated and untreated HIV infected and Uninfected Rwandan women. This study will assess insulin resistance by HIV serostatus and CD4 count utilizing previously collected data and specimens in Rwanda Women's Interassociation Study and Assessment (RWISA). RWISA is a prospective observational cohort study, established in September 2004, with 936 HIV-infected and uninfected women enrolled from May 15-November 15, 2005 and followed till 2008.
Jean Claude's research interest on HIV/AIDS arose from medical school after presenting his research thesis on nutritional status among HIV uninfected children born to HIV-infected mothers in Rwanda. Since then, he managed to participate in various International conferences on HIV/AIDS and other sexual transmitted infections including 16th International Conference on HIV/AIDS in Toronto (Canada), International conference on HIV/AIDS and STIs in Africa (Dakar Senegal), conference on retroviruses and opportunistic infection (CROI) in Montreal Canada and 2009 keystone symposia in Colorado(USA). Before joining Einstein, he attended other international research training workshops including a one-month HIV research training in Stockholm (Sweden), a 2 week-training on monitoring and evaluation of HIV/AIDS programs in Kabwe (Zambia).
After completing his training at Einstein, he plans to return to Rwanda to strengthen clinical research, which is among Rwandan government's priorities to achieve its vision 2020.